How Commercial Due Diligence Tests a Business Before a Deal

Commercial due diligence is the process of examining a business's market position, customers, competitors and revenue prospects before an investor or buyer commits money. It asks a simple question: is the business as attractive as its pitch suggests? For learners who want to study the discipline in a structured way, the course titled Micro Diploma: Commercial Due Diligence offers an organized introduction to these ideas. The work matters because most deal failures trace back to flawed assumptions about demand, pricing or competition rather than to accounting errors alone.

The core mechanics rest on a few linked questions. First, the analyst defines the market, estimating its size and growth using both top-down figures, such as industry reports, and bottom-up figures, such as the number of potential customers multiplied by expected spending. Second, the analyst tests the company's claims about customer acquisition, retention and pricing against actual data where it exists. Third, the analyst maps competitors and considers how they are likely to respond if the target grows.

Analysts often use frameworks such as market sizing funnels, customer cohort analysis and competitive positioning maps. These tools do not produce certainty. They structure judgment so that assumptions become visible and can be challenged, which is the real purpose of the exercise.

Consider a young startup team that has built a scheduling app for independent dental clinics and is seeking a seed investment. A commercial due diligence review would begin by checking how many independent clinics exist in the target region, how many already use digital scheduling, and how much they currently pay for comparable tools. The analyst would then compare the team's projected sign-up rate with what similar software products have achieved in adjacent markets, noting where the startup's assumptions are optimistic.

The review would also examine early customer evidence, such as pilot agreements, usage logs and reasons given for churn. If the team has only spoken with enthusiastic early adopters, the analyst would flag that sample as biased and suggest interviews with clinics that declined the product. The output is usually a memo that separates well-supported findings from claims that still need proof.

Commercial due diligence has real limitations. Markets change quickly, and a review completed before a deal can be outdated within months. Data for young companies is often thin, so analysts rely heavily on judgment, and two experienced reviewers can reach different conclusions from the same evidence. There is also a debate about how much weight to give founder projections versus independent benchmarks, and about whether reviews should go beyond the deal to test the company's long-term strategy.

The main takeaway is that commercial due diligence is most valuable when it makes assumptions explicit and tests them against evidence. As startups and investors increasingly work with limited historical data, the discipline is likely to depend more on careful customer research and transparent reasoning than on large volumes of reported figures.